Search company, investor...

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Series A | Dead

Total Raised


Last Raised


About Invenux

Developer of innovative drugs for out-licensing to strategic pharmaceutical partners. The company was formed to provide Evolutionary Chemistry in the medical field. This technology can be used to identify and optimize potentially valuable chemicals and is particularly suited to the discovery and optimization of pharmaceutical products for human use. Pharmaceutical companies collaborate with the company to discover products for identified but unmet medical needs. Unlike any other drug discovery technology, Evolutionary Chemistry has the potential to generate new, high-value small-molecule drugs from novel libraries of five to 50 million compounds for virtually any therapeutic indication. The company's integrated drug discovery system combines the chemical synthesis with the power of evolution to rapidly discover optimized compounds for the increasing number of drug targets identified by ongoing genomics research.

Invenux Headquarters Location

6840 North Broadway Suite F

Denver, Colorado, 80221,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

  • When was Invenux founded?

    Invenux was founded in 2000.

  • Where is Invenux's headquarters?

    Invenux's headquarters is located at 6840 North Broadway, Denver.

  • What is Invenux's latest funding round?

    Invenux's latest funding round is Series A.

  • How much did Invenux raise?

    Invenux raised a total of $6.7M.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.